University of Edinburgh
Edinburgh, United Kingdom
NCT Number: NCT03471494
Aim The aim is to determine the variation in quality of cancer surgery worldwide. Quality will be determined using measures covering infrastructure, care processes, and outcomes. The study will concentrate on the most common surgically treated cancers worldwide: breast, gastric and colorectal cancer. The primary aim focusses on 30-day mortality and complication rates after cancer surgery. The secondary aim is to characterise infrastructure and care processes in the treatment of these cancers worldwide.
Primary outcome measure 30-day mortality and complication rates after cancer surgery.
Primary comparison Between country groups defined by human development index.
Hospital eligibility Any hospital in the world performing surgery for breast, gastric or colorectal cancer.
Patient eligibility Consecutive patients undergoing surgery for breast, gastric, or colorectal cancer. Surgery can be with palliative or curative intent.
Team Individual hospital teams with up to three people, collecting data for four weeks. Several teams collecting data over multiple four-week periods is encouraged.
Time period Patients will be identified, and data collected on all patients during the time-period with follow-up to 30-days. The study will run from 1st April 2018 to 31st October 2018 (with follow-up of the last period to 30th November 2018).
Validation Data validation will be in two parts. First, centres will self-report the key processes used to identify and follow-up patients. Second, independent validators will quantitatively report case ascertainment and sampled data accuracy.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Edinburgh, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Primary comparison: Between country groups defined by human development index.
Time frame: 30 days from surgery
Death within 30 days of surgical procedure
Time frame: 30 days from surgery
Defined with by Clavien-Dindo grade III or IV
Time frame: Prior to surgery.
For breast cancer.
Time frame: Prior to surgery.
For breast cancer.
Time frame: Prior to surgery.
For breast cancer.
Time frame: Collection of variable within 30 days of surgery.
For breast cancer.
Time frame: During surgery.
For breast cancer.
Time frame: Prior to surgery.
For breast cancer.
Time frame: Within 31 days of completion of surgery.
For breast cancer.
Time frame: Collection of variable within 30 days of surgery.
For breast cancer.
Time frame: Collection of variable within 30 days of surgery.
For breast cancer.
Time frame: Prior to surgery.
For gastric cancer.
Time frame: Prior to surgery.
For gastric cancer.
Time frame: Prior to surgery.
For gastric cancer.
Time frame: Collection of variable within 30 days of surgery.
For gastric cancer.
Time frame: Prior to surgery.
For colon cancer.
Time frame: Prior to surgery.
For colon cancer.
Time frame: Collection of variable within 30 days of surgery.
For colon cancer.
Time frame: Prior to surgery.
For colon cancer.
Time frame: Prior to surgery.
For colon cancer.
Time frame: During surgery.
For colon cancer.
Time frame: Collection of variable within 30 days of surgery.
For colon cancer.
Time frame: Collection of variable within 30 days of surgery.
For colon cancer.
University of Edinburgh
Other
Acronym: GS3
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00600496
Breast Cancer, Breast Diseases
Detroit, Michigan, United States
View Trial DetailsNCT00041652
Breast Cancer, Breast Diseases
Newport Beach, California, United States
View Trial DetailsNCT00120939
Adnexal Diseases, Astrocytoma
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT00001805
Breast Diseases, Breast Neoplasms
Bethesda, Maryland, United States
View Trial Details